AKTX
Akari Therapeutics, Plc
NASDAQ · Healthcare · Biotechnology · GB
$11.77
+8.58%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-27.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | Farag Kameel D. · officer: Interim CFO | A-Award | 1,728 | $7.52 |
| Aug 5, 2026 | Farag Kameel D. · officer: Interim CFO | A-Award | 1,130 | $12 |
| Jul 17, 2026 | Patel Samir Rashmikant · director, 10 percent owner: | M-Exempt | 1,209 | $8.00 |
| Jul 17, 2026 | Patel Samir Rashmikant · director, 10 percent owner: | M-Exempt | 15,466 | $0.00 |
| Jul 17, 2026 | Patel Samir Rashmikant · director, 10 percent owner: | M-Exempt | 5,799 | $0.00 |
| Jun 25, 2026 | Gaslightwala Abizer · director, officer: CEO | A-Award | 5,500 | $4.64 |
| Jun 25, 2026 | Gaslightwala Abizer · director, officer: CEO | A-Award | 15,563 | $15 |
| Jun 25, 2026 | Farag Kameel D. · officer: Interim CFO | A-Award | 1,395 | $9.32 |
| Jun 25, 2026 | Farag Kameel D. · officer: Interim CFO | A-Award | 2,539 | $5.12 |
| Jun 25, 2026 | Farag Kameel D. · officer: Interim CFO | A-Award | 3,725 | $3.49 |
| Jun 25, 2026 | Farag Kameel D. · officer: Interim CFO | A-Award | 7,353 | $3.74 |
| Jun 25, 2026 | Farag Kameel D. · officer: Interim CFO | A-Award | 1,000 | $13 |
| Jun 25, 2026 | Farag Kameel D. · officer: Interim CFO | A-Award | 1,248 | $10 |
| Jun 25, 2026 | Farag Kameel D. · officer: Interim CFO | A-Award | 1,570 | $8.28 |
| Mar 16, 2026 | Neal James R · director | Purchase | 2,473 | $0.39 |
| Mar 16, 2026 | Neal James R · director | Purchase | 3,093 | $0.39 |
| Dec 18, 2025 | Gaslightwala Abizer · director, officer: CEO | Purchase | 309,328 | $0.00 |
| Dec 18, 2025 | Prudo-Chlebosz Raymond · director | Purchase | 386,661 | $0.39 |
| Dec 18, 2025 | Patel Sandip I · director | Purchase | 247,462 | $0.00 |
| Dec 18, 2025 | Patel Sandip I · director | Purchase | 154,664 | $0.39 |
| Dec 18, 2025 | Huh Hoyoung · director, 10 percent owner: | Purchase | 3,093,293 | $0.39 |
| Dec 18, 2025 | Huh Hoyoung · director, 10 percent owner: | Purchase | 618,658 | $0.39 |
| Dec 18, 2025 | Farag Kameel D. · officer: Interim CFO | Purchase | 24,745 | $0.39 |
| Dec 18, 2025 | Patel Samir Rashmikant · director, 10 percent owner: | Purchase | 618,658 | $0.39 |
| Dec 18, 2025 | Patel Samir Rashmikant · director, 10 percent owner: | Purchase | 231,997 | $0.39 |
| Dec 18, 2025 | Gaslightwala Abizer · director, officer: CEO | Purchase | 773,323 | $0.39 |
| Dec 18, 2025 | Bazemore Robert B · director | Purchase | 123,731 | $0.39 |
| Dec 18, 2025 | Bazemore Robert B · director | Purchase | 30,932 | $0.00 |
| Dec 18, 2025 | Prudo-Chlebosz Raymond · director | Purchase | 618,658 | $0.00 |
| Nov 4, 2025 | Farag Kameel D. · officer: Interim CFO | A-Award | 26,619 | $0.75 |
Institutional positioning
13F filings over the trailing two quarters
New 2Increased 0Reduced 5Sold out 6
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | Reduced | 38,922 | May 15, 2026 |
| CRESSET ASSET MANAGEMENT, LLC | Reduced | 20,561 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 10,000 | Sep 2, 2026 |
| IFP ADVISORS, INC | New Position | 7,431 | Apr 13, 2026 |
| SBI SECURITIES CO., LTD. | Reduced | 5 | Apr 28, 2026 |
| MORGAN STANLEY | Reduced | 1 | May 15, 2026 |
| TRUVESTMENTS CAPITAL LLC | Reduced | 1 | May 13, 2026 |
| SBI Securities Co., Ltd. | Sold Out | 0 | Apr 28, 2026 |
| ARMISTICE CAPITAL, LLC | Sold Out | 0 | May 15, 2026 |
| Cresset Asset Management, LLC | Sold Out | 0 | May 15, 2026 |
| IFP Advisors, Inc | Sold Out | 0 | Apr 13, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 15, 2026 |
| Truvestments Capital LLC | Sold Out | 0 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 19, 2026